XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. (2023)

First Author: Fisher JG
Attributed to:  Targeting natural killer cell receptors for immunotherapeutic benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-023-01984-z

PubMed Identifier: 37528310

Publication URI: http://europepmc.org/abstract/MED/37528310

Type: Journal Article/Review

Volume: 37

Parent Publication: Leukemia

Issue: 10

ISSN: 0887-6924